• Cetrelimab ELISA Kit
1 1

AntibodySystem

KDH02202

Cetrelimab ELISA Kit

Cetrelimab ELISA Kit

Title

Catalog No.: KDH02202

Catalog No. KDH02202
Product name Cetrelimab ELISA Kit
Size 96 T
Description PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human CD279 has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Cetrelimab in the sample competitively binds to the pre-coated protein with biotin-labeled Cetrelimab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Cetrelimab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications Used for the quantitative determination of Cetrelimab concentration in serum and plasma.
Stability and Storage When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Detection method Colorimetric
Precision CV<20%
Sample type Plasma, Serum
Assay type Quantitative
Sensitivity 13.86 ng/mL
Range 156.25 - 10,000 ng/mL
Recovery 80-120%
Background Cetrelimab (JNJ-63723283) is an IgG4, anti-programmed cell death protein-1 (PD-1) antibody. Here we present updated results from an ongoing phase 1/2 study of cetrelimab in patients (pts) with advanced or refractory solid cancers.
Alternative Names JNJ-63723283, CAS: 2050478-92-5
Shipping 2-8 ℃
Note For Research Use Only.
전체 세부 정보 보기